financetom
POST
financetom
/
Consumer Staples
/
POST
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Post Holdings, Inc.POST
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Post Holdings, Inc. operates as a consumer packaged goods holding company in the United States and internationally.

It operates through four segments: Post Consumer Brands, Weetabix, Foodservice, and Refrigerated Retail.

The Post Consumer Brands segment manufactures, markets, and sells branded and private label ready-to-eat (RTE) cereals under Honey Bunches of Oats, Pebbles, and Malt-O-Meal brand names; hot cereal; peanut butter under the Peter Pan brand; and branded and private label dog and cat food products under Rachael Ray Nutrish, Nature's Recipe, 9Lives, Kibbles 'n Bits and Gravy Train brand names.

The Weetabix segment primarily manufactures, markets, and distributes branded and private label RTE cereal under Weetabix and Alpen brands; hot cereals and other cereal-based food products; breakfast drinks; protein-based shakes under the UFIT brand, and nutritional snacks, such as muesli.

The Foodservice segment produces and distributes egg products primarily under Papetti's and Abbotsford Farms brands, as well as potato products in the foodservice and food ingredient channels.

The segment also manufactures certain meat products. The Refrigerated Retail segment produces and distributes side dish, potato, sausage products under Bob Evans, Bob Evans Farms, and Simply Potatoes brands; eggs and egg products under Bob Evans Egg Whites and Egg Beaters brands; and cheese, and other dairy and refrigerated products under Crystal Farms brand.

It serves grocery stores, mass merchandise customers, supercenters, club stores, natural/specialty stores, dollar stores, discounters, wholesalers, convenience stores, pet supply retailers, drug store customers, foodservice distributors, and national restaurant chains, as well as sells its products in the military, ecommerce, and foodservice channels.

The company was founded in 1895 and is headquartered in Saint Louis, Missouri.

Latest News >
GM, LG to make new, lower-cost cells for future EVs
GM, LG to make new, lower-cost cells for future EVs
May 26, 2025
DETROIT (Reuters) -General Motors ( GM ) and battery partner LG Energy Solution are planning to start commercial production of lower-cost cells for future electric vehicles at a U.S. facility starting in 2028, the companies said on Tuesday.  The cells will have a lithium manganese-rich (LMR) chemistry, which GM says is lower cost than the nickel-rich cells used today, but...
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
May 26, 2025
10:05 AM EDT, 05/13/2025 (MT Newswires) -- OMS Energy Technologies ( OMSE ) said Tuesday it priced its initial public offering of about 3.7 million ordinary shares at $9 per share. The total base offering size is $33.3 million, assuming the underwriters don't exercise their 45-day option to buy up to 555,555 additional ordinary shares at the IPO price, the...
Bank of America to open more than 150 new branches by 2027
Bank of America to open more than 150 new branches by 2027
May 26, 2025
May 13 (Reuters) - Bank of America ( BAC ) plans to open more than 150 new branches by the end of 2027, it said on Tuesday, as part of the lender's efforts to expand its physical presence across the United States. The bank will open 40 new branches this year, with an additional 70 sites planned for 2026, it...
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
May 26, 2025
10:03 AM EDT, 05/13/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said Tuesday that its BMB-101 showed a complete elimination of drop attacks in the DBA/2 mouse model of epilepsy. Notably, BMB-101 achieved 100% survival in the DBA/2 model, reversing brainstem serotonin deficits and preventing seizure-induced respiratory arrest, Jan Torleif Pedersen, the company's chief science officer, said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved